ENPP1 variants in patients with GACI and PXE expand the clinical and genetic heterogeneity of heritable disorders of ectopic calcification
Authors:
- Douglas RalphDRDouglas Ralph
- Yvonne NitschkeYNYvonne Nitschke
- Michael A. LevineMLMichael A. Levine
- Matthew CaffetMCMatthew Caffet
- Tamara WurstTWTamara Wurst
- Amir Hossein SaeidianASAmir Hossein Saeidian
- Leila YoussefianLYLeila Youssefian
- Hassan VahidnezhadHVHassan Vahidnezhad
- Sharon F. TerrySTSharon F. Terry
- Qiaoli LiQLQiaoli Li
Open Access
- 28 April 2022
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS Genetics
- Vol. 18 (4) , e1010192
Abstract
Pseudoxanthoma elasticum (PXE) and generalized arterial calcification of infancy (GACI) are clinically distinct genetic entities of ectopic calcification associated with differentially reduced circulating levels of inorganic pyrophosphate (PPi), a potent endogenous inhibitor of calcification. Variants in ENPP1, the gene mutated in GACI, have not been associated with classic PXE. Here we report the clinical, laboratory, and molecular evaluations of ten GACI and two PXE patients from five and two unrelated families registered in GACI Global and PXE International databases, respectively. All patients were found to carry biallelic variants in ENPP1. Among ten ENPP1 variants, one homozygous variant demonstrated uniparental disomy inheritance. Functional assessment of five previously unreported ENPP1 variants suggested pathogenicity. The two PXE patients, currently 57 and 27 years of age, had diagnostic features of PXE and had not manifested the GACI phenotype. The similarly reduced PPi plasma concentrations in the PXE and GACI patients in our study correlate poorly with their disease severity. This study demonstrates that in addition to GACI, ENPP1 variants can cause classic PXE, expanding the clinical and genetic heterogeneity of heritable ectopic calcification disorders. Furthermore, the results challenge the current prevailing concept that plasma PPi is the only factor governing the severity of ectopic calcification.Keywords
Funding Information
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (R01AR072695)
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (R01AR072695)
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (R21AR077332)
This publication has 41 references indexed in Scilit:
- Cutaneous features of pseudoxanthoma elasticum in a patient with generalized arterial calcification of infancy due to a homozygous missense mutation in theENPP1geneBritish Journal of Dermatology, 2012
- Generalized Arterial Calcification of Infancy and Pseudoxanthoma Elasticum Can Be Caused by Mutations in Either ENPP1 or ABCC6The American Journal of Human Genetics, 2012
- Expression and In Vivo Rescue of Human ABCC6 Disease-Causing Mutants in Mouse LiverPLOS ONE, 2011
- Robust relationship inference in genome-wide association studiesBioinformatics, 2010
- Autosomal-Recessive Hypophosphatemic Rickets Is Associated with an Inactivation Mutation in the ENPP1 GeneThe American Journal of Human Genetics, 2010
- Loss-of-Function ENPP1 Mutations Cause Both Generalized Arterial Calcification of Infancy and Autosomal-Recessive Hypophosphatemic RicketsThe American Journal of Human Genetics, 2010
- Hypophosphatemia, Hyperphosphaturia, and Bisphosphonate Treatment Are Associated With Survival Beyond Infancy in Generalized Arterial Calcification of InfancyCirculation: Cardiovascular Genetics, 2008
- Mutation detection in the ABCC6 gene and genotype phenotype analysis in a large international case series affected by pseudoxanthoma elasticumJournal of Medical Genetics, 2007
- Generalized arterial calcification of infancy: two siblings with prolonged survivalEuropean Journal of Pediatrics, 2005
- Generalized arterial calcification of infancy: Three case reports, including spontaneous regression with long-term survivalThe Journal of Pediatrics, 1984